Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (501-510 of 646) with videos related to

Pageof 65
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to TherapyBartolome R Celli, Stephanie Christenson, Klaus F Rabe, et al.
The European Respiratory Journal|April 2, 2014
The European Respiratory Society plans its future: the 2013-2018 strategic planGiovanni Battista Migliori, Klaus F Rabe, Elisabeth Bel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 16, 2003
Proliferation and inflammation in bronchial epithelium after allergen in atopic asthmaticsF L M Ricciardolo, A Di Stefano, J H J M van Krieken, et al.
American Journal of Respiratory and Critical Care Medicine|November 30, 2020
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group StudyFernando J Martinez, Klaus F Rabe, Gary T Ferguson, et al.
The New England Journal of Medicine|June 25, 2020
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPDKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
Diagnostic Pathology|July 29, 2015
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?I Watermann, B Schmitt, F Stellmacher, et al.
Clinical Epigenetics|February 18, 2021
DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancerTorsten Goldmann, Bernhard Schmitt, Julia Müller, et al.
International Journal of Cardiology|May 31, 2016
Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general populationChristina Baum, Francisco M Ojeda, Philipp S Wild, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
Respiratory Research|March 24, 2011
Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPDLisette I Z Kunz, Thérèse S Lapperre, Jiska B Snoeck-Stroband, et al.
Pageof 65

Showing results (501-510 of 646) with videos related to

Sort By:
Pageof 65
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to TherapyBartolome R Celli, Stephanie Christenson, Klaus F Rabe, et al.
The European Respiratory Journal|April 2, 2014
The European Respiratory Society plans its future: the 2013-2018 strategic planGiovanni Battista Migliori, Klaus F Rabe, Elisabeth Bel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 16, 2003
Proliferation and inflammation in bronchial epithelium after allergen in atopic asthmaticsF L M Ricciardolo, A Di Stefano, J H J M van Krieken, et al.
American Journal of Respiratory and Critical Care Medicine|November 30, 2020
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group StudyFernando J Martinez, Klaus F Rabe, Gary T Ferguson, et al.
The New England Journal of Medicine|June 25, 2020
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPDKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
Diagnostic Pathology|July 29, 2015
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?I Watermann, B Schmitt, F Stellmacher, et al.
Clinical Epigenetics|February 18, 2021
DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancerTorsten Goldmann, Bernhard Schmitt, Julia Müller, et al.
International Journal of Cardiology|May 31, 2016
Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general populationChristina Baum, Francisco M Ojeda, Philipp S Wild, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
Respiratory Research|March 24, 2011
Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPDLisette I Z Kunz, Thérèse S Lapperre, Jiska B Snoeck-Stroband, et al.
Pageof 65